Enterprise HL7 / FHIR Terminology Engine
Universal Clinical Codes & Terminology Search
Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.
Showing 20 of 12623 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
| Code Value | Display Description | Code System & OID | FHIR Resource | Category | Status | Actions |
|---|---|---|---|---|---|---|
|
0535T
|
Continuous recording of movement disorder symptoms including bradykinesia dyskinesia and tremor for 6 days up to 10 days; data upload analysis and initial report configuration
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0535U
|
Perfluoroalkyl substances (PFAS) (eg perfluorooctanoic acid perfluorooctane sulfonic acid) by liquid chromatography with tandem mass spectrometry (LC-MS/MS) plasma or serum quantitative
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0536T
|
Continuous recording of movement disorder symptoms including bradykinesia dyskinesia and tremor for 6 days up to 10 days; download review interpretation and report
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0536U
|
Red blood cell antigen (fetal RhD) PCR analysis of exon 4 of RHD gene and housekeeping control gene GAPDH from whole blood in pregnant individuals at 10+ weeks gestation known to be RhD negative reported as fetal RhD status
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0537T
|
Chimeric antigen receptor T-cell (CAR-T) therapy; harvesting of blood-derived T lymphocytes for development of genetically modified autologous CAR-T cells per day
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0537U
|
Oncology (colorectal cancer) analysis of cell-free DNA for epigenomic patterns next-generation sequencing >2500 differentially methylated regions (DMRs) plasma algorithm reported as positive or negative
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0538T
|
Chimeric antigen receptor T-cell (CAR-T) therapy; preparation of blood-derived T lymphocytes for transportation (eg cryopreservation storage
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0538U
|
Oncology (solid tumor) next-generation targeted sequencing analysis formalin-fixed paraffin-embedded (FFPE) tumor tissue DNA analysis of 600 genes interrogation for single-nucleotide variants insertions/deletions gene rearrangements and copy number alterations microsatellite instability tumor mutation burden reported as actionable variant
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0539T
|
Chimeric antigen receptor T-cell (CAR-T) therapy; receipt and preparation of CAR-T cells for administration
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0539U
|
Oncology (solid tumor) cell-free circulating tumor DNA (ctDNA) 152 genes next-generation sequencing interrogation for single-nucleotide variants insertions/deletions gene rearrangements copy number alterations and microsatellite instability using whole-blood samples mutations with clinical actionability reported as actionable variant
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0540F
|
Glucorticoid Management Plan Documented (RA)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Patient Management | Active |
|
|
0540T
|
Chimeric antigen receptor T-cell (CAR-T) therapy; CAR-T cell administration autologous
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0540U
|
Transplantation medicine quantification of donor-derived cell-free DNA using next-generation sequencing analysis of plasma reported as percentage of donor-derived cell-free DNA to determine probability of rejection
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0541T
|
Myocardial imaging by magnetocardiography (MCG) for detection of cardiac ischemia by signal acquisition using minimum 36 channel grid generation of magnetic-field time-series images quantitative analysis of magnetic dipoles machine learning-derived clinical scoring and automated report generation single study;
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0541U
|
Cardiovascular disease (HDL reverse cholesterol transport) cholesterol efflux capacity LC-MS/MS quantitative measurement of 5 distinct HDL-bound apolipoproteins (apolipoproteins A1 C1 C2 C3 and C4) serum algorithm reported as prediction of coronary artery disease (pCAD) score
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0542T
|
Myocardial imaging by magnetocardiography (MCG) for detection of cardiac ischemia by signal acquisition using minimum 36 channel grid generation of magnetic-field time-series images quantitative analysis of magnetic dipoles machine learning-derived clinical scoring and automated report generation single study; interpretation and report
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0542U
|
Nephrology (renal transplant) urine nuclear magnetic resonance (NMR) spectroscopy measurement of 84 urinary metabolites combined with patient data quantification of BK virus (human polyomavirus 1) using real-time PCR and serum creatinine algorithm reported as a probability score for allograft injury status
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0543T
|
Transapical mitral valve repair including transthoracic echocardiography when performed with placement of artificial chordae tendineae
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0543U
|
Oncology (solid tumor) next-generation sequencing of DNA from formalin-fixed paraffin-embedded (FFPE) tissue of 517 genes interrogation for single-nucleotide variants multi-nucleotide variants insertions and deletions from DNA fusions in 24 genes and splice variants in 1 gene from RNA and tumor mutation burden
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0544T
|
Transcatheter mitral valve annulus reconstruction with implantation of adjustable
annulus reconstruction device percutaneous approach including transseptal puncture
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD
In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside
Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.
An OID is an internationally standardized dotted-decimal identifier (e.g.
2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.
Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.